BARCELONA, Spain — Data on the controversial topic of testosterone replacement therapy in men with prostate cancer will be in the spotlight here at the European Association of Urology (EAU) 2019 ...

Testosterone replacement therapy (TRT) is indicated in hypogonadal symptomatic men, where contraindications to treatment do not exist. The International Society for the Study of the Aging Male ...

DEAR DR. ROACH: Approximately five years ago, I was diagnosed with an aggressive prostate cancer. My urologist referred me for radiation therapy, to be followed by Lupron every six months for two ...

Prostate cancer is the most common cancer in men throughout the United States. Most men do not realize they have cancer due ...

BOSTON – A retrospective analysis by researchers at Beth Israel Deaconess Medical Center published in The New England Journal of Medicine found no causal relationship between testosterone replacement ...

Most people with prostate cancer won’t die from it. But it still kills more American men than any type of cancer except lung cancer, because prostate cancer is more common. Prostate cancer needs ...

Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2–Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized ...

Dulaglutide Approved for Type 2 Diabetes Testosterone replacement therapy (TRT) may promote prostate cancer tumor growth. A study from a group of researchers at the University of Illinois in Chicago ...

Findings emerge from a study of hypogonadal men who underwent radiation therapy, surgery, or active surveillance for prostate cancer. Testosterone replacement therapy (TRT) does not worsen oncologic ...

You have full access to this article via your institution. The results of the present study showed that TRT of 1 year of duration did not effect PSA levels significantly (most PSA rise below 0.5 ng/ml ...